Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Relay Medical

Relay Medical?uq=2zON1W4M
2005 FOUNDED
PUBLIC STATUS
RELA STOCK SYMBOL
2 INVESTMENTS
$0.16 SHARE PRICE (As of Thursday Closing)
Description

Developer of medical devices for in vitro diagnostics and point-of-care testing. The company's medical devices consists of the HemoPalm platform, a combination of full CO-oximetry and blood gases in one handheld analyzer and the Automatic Ultra-filtration (AUF) which allow the preparation of ultra-filtrates of serum and plasma samples for measurement of free therapeutic drugs and hormones, enabling pharmaceutical companies to receive innovative devices for blood collection, analysis and plasma/serum processing.

Formerly Known As
ChroMedX
Ownership Status
Publicly Held
Financing Status
Corporate Backed or Acquired
Primary Industry
Monitoring Equipment
Other Industries
Other Devices and Supplies
Stock Exchange
CNQ
Primary Office
  • 65 Queen Street West
  • Suite 520
  • Toronto, Ontario M5H 2M5
  • Canada

+1 (647) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Relay Medical’s full profile, request a free trial.

Relay Medical Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$0.15 - $0.60 $15.7M $0.15 -$0.07 102K 102M

Relay Medical Financials Summary

In Thousands,
USD
TTM
30-Jun-2018
FY 2017
30-Sep-2017
FY 2016
30-Sep-2016
FY 2015
30-Sep-2015
Enterprise Value 17,177 16,160 5,040 9,962
EBITDA (5,410) (2,455) (831) (1,438)
Net Income (5,924) (2,952) (1,324) (1,712)
Total Assets 4,273 1,840 1,948 2,597
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Relay Medical Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Relay Medical‘s full profile, request access.

Request full access to PitchBook

Relay Medical Investments & Acquisitions (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000000000 0000 23-Aug-2018 000000000 00000 00 Other Healthcare 00000 000
UX Data Sciences 24-May-2018 Merger/Acquisition 00.000 Monitoring Equipment 00000 000
To view this company’s complete investment and acquisition history, request access »

Relay Medical Subsidiaries (1)

Company Name Industry Location Founded
00 0000 00000000 Monitoring Equipment Ottawa, Canada 0000
To view this company’s complete subsidiary history, request access »

Relay Medical Executive Team (8)

Name Title Board
Seat
Contact
Info
W. Clark Kent President & Director
Christopher Hopkins Chief Financial Officer
Jessica Kuhn Chief Operating Officer
James Samsoondar Ph.D Co-Founder, Director & Chief Scientific Officer
Tom Glawdel Ph.D Chief Science Officer & Science lead for the HemoPalm platform

1 Former Executive

You’re viewing 5 of 8 executives. Get the full list »